Stockreport

NovaBay Pharmaceuticals Signs Agreement to Distribute COVID-19 Antibody Rapid Point-of-Care Test to U.S. Healthcare Professionals

NovaBay Pharmaceuticals, Inc.  (NBY) 
NASDAQ:AMEX Investor Relations: novabay.com/investors
PDF Company to submit the ISO 13485 and CE Mark certified fluorecare® test kit under FDA’s EAU and 510(k) clearance for U.S. commercial use EMERYVILLE, Calif.--(BUSINESS [Read more]